Assessment of sleepiness and unintended sleep in Parkinson's disease patients taking dopamine agonists

Sleep Medicine

Volumn 4, Issue 4, 2003, Pages 275-280

  Roth, Thomas ^a   Rye, David B ^b   Borchert, Leona D ^c   Bartlett, Cindy ^d   Bliwise, Donald L ^b   Cantor, Charles ^e   Gorell, Jay M ^a   Hubble, Jean P ^f   Musch, Bruno ^c   Olanow, C Warren ^g   Pollak, Charles ^f   Stern, Matt B ^e   Watts, Ray L ^b  

^a HENRY FORD HOSPITAL   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PFIZER INC   (United States)

^d Pharmacia Canada   (Canada)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f OHIO STATE UNIVERSITY   (United States)

^g MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Excessive daytime sleepiness; Multiple sleep latency test; Polysomnography; Pramipexole

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; FEMALE; HUMAN; LEG MOVEMENT; MALE; MEDICAL ASSESSMENT; PARKINSON DISEASE; POLYSOMNOGRAPHY; PRESCRIPTION; PRIORITY JOURNAL; RATING SCALE; REM SLEEP; RESTLESS LEGS SYNDROME; SCORING SYSTEM; SELF REPORT; SLEEP; SLEEP STAGE; SLEEP TIME; SOMNOLENCE;

EID: 0041562710     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1389-9457(03)00058-3     Document Type: Article

References (36)

1. Lees AJ, Blackburn NA, Campbell VL. The nighttime problems of Parkinson's disease. Clin Neuropharmacol 1988;11:512-9.
2. Rye D, Bliwise D. Movement disorders specific to sleep and the nocturnal manifestations of waking movement disorders. In: Watts R, Koller W, editors. Movement disorders: neurologic principles and practice. New York, NY: McGraw-Hill; 1997. p. 687-713.
3. Askenazy JJM, Yahr MD. Sleep in Parkinson's disease. Acta Neurol Scand 1990;87:167-70.
4. Stocchi F, Barbato L, Nordera G, Berardelli A, et al. Sleep disorders in Parkinson's disease. J Neurol 1998;245(Suppl. 1):S15-S18.
5. Aldrick M. Parkinsonism. In: Kryger M, Roth T, Dement WC, editors. Principles and practice of sleep medicine. Philadelphia, PA: WB Saunders Co; 2000. p. 1051-7.
6. El-Ad B, Korczyn AD. Disorders of excessive daytime sleepiness - an update. J Neurol Sci 1998;153:192-202.
7. Larsen JP, Tandberg E. Sleep disorders in patients with Parkinson's disease: epidemiology and management. CNS Drugs 2001;15: 267-75.
8. van Hilten B, Hoff JI, Middelkoop HA, van der Velde EA, et al. Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoring. Arch Neurol 1994;51:922-8.
9. Factor SA, McAlarney T, Sanchez-Ramos JR, Weiner WJ. Sleep disorders and sleep effect in Parkinson's disease. Mov Disord 1990;5: 280-5.
10. Roth T, Roehrs T. Etiologies and sequelae of excessive daytime sleepiness. Clin Ther 1996;8:562-76.
11. Tandberg E, Larsen JP, Karlsen K. Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study. Mov Disord 1999;14:922-7.
12. Rye DB, Bliwise DL, Dihenia B, Gurecki P. FAST TRACK: daytime sleepiness in Parkinson's disease. J Sleep Res 2000;9:63-9.
13. Arnulf I, Konofal E, Merino-Andreu M, Houeto JL, et al. Parkinson's disease and sleepiness: an integral part of PD. Neurology 2002;58: 1019-24.
14. Hobson DE, Lang AE, Martin WRW, Razmy A, et al. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease. A survey by the Canadian Movement Disorders Group. J Am Med Assoc 2002;(287):455-63.
15. Parkinson Study Group, Safety and efficacy of pramipexole in early Parkinson disease. A randomized dose-ranging study. J Am Med Assoc 1997;278:125-30.
16. Sethi KD, O'Brien CF, Hammerstad JP, Adler CH, et al. For the Ropinirole Study Group. Ropinirole for the treatment of early Parkinson disease. Arch Neurol 1998;55:1211-6.
17. Frucht S, Rogers JD, Greene PF, Gordon MF, et al. Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 1999;52:1908-10.
18. Olanow CW, Schapira AHV, Roth T. Falling asleep at the wheel: motor vehicle mishaps in people taking pramipexole and ropinirole [letter]. Neurology 2000;54:274.
19. Ferreira JJ, Galitzky M, Montastruc JL, Rascol O. Sleep attacks and Parkinson's disease treatment [letter]. Lancet 2000;355:1333-4.
20. Rye D, Johnston L, Watts R, Bliwise D. Juvenile Parkinson's disease with REM behavior disorder, sleepiness and daytime REM-onsets. Neurology 1999;53:1868-70.
21. Rye DB, Jankovic J. Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD. Neurology 2002;58: 341-6.
22. Johns MW. Sleepiness in different situations measured by the Epworth Sleepiness Scale. Sleep 1994;17:703-10.
23. van Ert PM, Gapinski JP, Fuller MJ, Stevenson JE. The predictive value of the Epworth Sleepiness Scale: patient vs. significant other assessment of patient sleepiness. Sleep Research 1999;22(1).
24. Carskadon M. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep 1986;9:519-24.
25. Reynolds 3rd CF, Coble PA, Kupfer DJ, Holzer BC. Application of the multiple sleep latency test in disorders of excessive sleepiness. Electroenceph clin Neurophysiol 1982;53:443-52.
26. Richardson GS, Carskadon MA, Flagg W, van den Hoed J, et al. Excessive daytime sleepiness in man: multiple sleep latency measurement in narcoleptic and control subjects. Electroenceph clin Neurophysiol 1978;45:621-7.
27. Lavigne GJ, Manzini C. Bruxism. In: Kryger M, Roth T, Dement WC, editors. Principles and practice of sleep medicine. Philadelphia, PA: WB Saunders Co; 2000. p. 773-85.
28. Lowe AA. Oral appliances for sleep breathing disorders. In: Kryger TM, Roth T, Dement WC, editors. Principles and practice of sleep medicine. Philadelphia, PA: WB Saunders Co; 2000. p. 929-39.
29. Bliwise DL, Willians ML, Irbe D, Pour Ansari F, et al. Inter-rater reliability for identification of REM sleep in Parkinson's disease. Sleep 2000;23:671-6.
30. Wetter TC, Brunner H, Hogl B, Yassouridis A, et al. Increased alpha activity in REM sleep in do novo patients with Parkinson's disease. Mov Disord 2001;16:928-33.
31. Roehrs T, Zorick F, Sicklesteel J, Wittig R, et al. Excessive daytime sleepiness associated with insufficient sleep. Sleep 1983;6:319-25.
32. Gjerstad MD, Aarsland D, Larsen JP. Daytime somnolence over time in Parkinson's disease. Neurology 2002;58:1544-6.
33. Richardson JW, Fredrickson PA, Lin SC. Narcolepsy update. Mayo Clin Proc 1990;65:991-8.
34. Hauser RA, Gauger L, Anderson WM, Zesiewicz TA. Pramipexole-induced somnolence and episodes of daytime sleep. Mov Disord 2000;15:658-63.
35. Tracik F, Ebersbach G. Sudden daytime sleep onset in Parkinson's disease: polysomnographic recordings. Mov Disord 2001;16:500-6.
36. Ferreira JJ, Galitzky M, Thalamas C, Tiberge M, et al. Effect of ropinirole on sleep onset: a randomized, placebo-controlled study in healthy volunteers. Neurology 2002;58:460-2.